Lucid Diagnostics (LUCD) Gains from Investment Securities (2020 - 2026)

Lucid Diagnostics (LUCD) has 7 years of Gains from Investment Securities data on file, last reported at $17000.0 in Q1 2026.

• For the quarter ending Q1 2026, Gains from Investment Securities fell 99.83% year-over-year to $17000.0; the trailing twelve-month figure through Dec 2025 stood at $10.3 million (up 1649.15% YoY), and the FY2025 full-year result was $10.3 million, up 1649.15% from the prior year.
• Gains from Investment Securities for Q1 2026 stood at $17000.0, down from $10.3 million in the prior quarter.
• Across five years, Gains from Investment Securities topped out at $10.3 million in Q4 2025 and bottomed at $17000.0 in Q1 2026.
• The 5-year median for Gains from Investment Securities is $590662.0 (2023), against an average of $3.1 million.
• The widest annual swing landed in 2025, when Gains from Investment Securities soared 1802.63%; it then tumbled 99.83% in 2026.
• A 5-year view of Gains from Investment Securities shows it stood at $2.6 million in 2022, then surged by 114.56% to $5.5 million in 2023, then plunged by 89.33% to $587292.0 in 2024, then surged by 1649.15% to $10.3 million in 2025, then slumped by 99.83% to $17000.0 in 2026.
• The last three Gains from Investment Securities figures came in at $17000.0 (Q1 2026), $10.3 million (Q4 2025), and $472336.0 (Q3 2025), per Business Quant data.

Peer Comparison